Whitelab Genomics
Series BParis, FranceOct 2026
Whitelab Genomics raised €23M in a Series B round in Oct 2026. The company is based in Paris, France. Investors in the round: AVP, Blast.club, Debiopharm Innovation Fund and 2 others. Data as of Nov 2026.
Amount raised
€23M
€23,200,000
Native amount
23,200,000 EUR
Stage
Series B
series b
Investors
5
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €23M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
5 namedDate
Oct 2026
Round type
series b
Amount (EUR)
€23M
Other rounds
same companyRelated news
- Whitelab Genomics Raises $10M in Series A Fundingfinsmes.com · 2022-09
- eu-startups.com